Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


29.10.2018

1 Am Heart J
1 Am J Kidney Dis
1 Angiology
2 Biochem Biophys Res Commun
2 Br J Ophthalmol
1 Circ Genom Precis Med
7 Circulation
9 Diabet Med
8 Diabetes
11 Diabetes Care
1 Diabetes Educ
4 Diabetes Obes Metab
4 Diabetologia
1 Hypertension
4 Invest Ophthalmol Vis Sci
1 J Am Soc Nephrol
4 J Clin Endocrinol Metab
2 J Diabetes Complications
1 JAMA
1 Med J Aust
1 Metabolism
1 Nature
1 Nutr Metab (Lond)
2 Pediatr Diabetes
5 PLoS One
1 Retina
1 Stroke


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. PRADHAN AD, Paynter NP, Everett BM, Glynn RJ, et al
    Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.
    Am Heart J. 2018;206:80-93.
    PubMed     Text format     Abstract available


    Am J Kidney Dis

  2. UMANATH K, Lewis JB
    Diabetic Kidney Disease: The Tiger May Have New Stripes.
    Am J Kidney Dis. 2018;72:631-633.
    PubMed     Text format    


    Angiology

  3. KARAKURT M, Acar B, Ozeke O, Ozbay MB, et al
    From the Obesity Tsunami to the Diabetes Avalanche: Primordial Prevention of the Diabesity-Related Cardiovascular Epidemic by Diabeto-Cardiologists.
    Angiology. 2018 Oct 24:3319718808921. doi: 10.1177/0003319718808921.
    PubMed     Text format    


    Biochem Biophys Res Commun

  4. LIU HN, Cao NJ, Li X, Qian W, et al
    Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1.
    Biochem Biophys Res Commun. 2018 Oct 15. pii: S0006-291X(18)32198.
    PubMed     Text format     Abstract available

  5. ZHANG Y, Chen X, Yuan L, Zhang Y, et al
    Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway.
    Biochem Biophys Res Commun. 2018 Oct 22. pii: S0006-291X(18)32116.
    PubMed     Text format     Abstract available


    Br J Ophthalmol

  6. BEK T, Stefansson E, Hardarson SH
    Retinal oxygen saturation is an independent risk factor for the severity of diabetic retinopathy.
    Br J Ophthalmol. 2018 Oct 18. pii: bjophthalmol-2018-312764.
    PubMed     Text format     Abstract available

  7. FENWICK EK, Man REK, Gan ATL, Kumari N, et al
    Beyond vision loss: the independent impact of diabetic retinopathy on vision-related quality of life in a Chinese Singaporean population.
    Br J Ophthalmol. 2018 Oct 25. pii: bjophthalmol-2018-313082.
    PubMed     Text format     Abstract available


    Circ Genom Precis Med


  8. Correction to: Birthweight, Type 2 Diabetes Mellitus, and Cardiovascular Disease: Addressing the Barker Hypothesis With Mendelian Randomization.
    Circ Genom Precis Med. 2018;11:e000051.
    PubMed     Text format    


    Circulation

  9. CLAGGETT B, Lachin JM, Hantel S, Fitchett D, et al
    Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.
    Circulation. 2018;138:1599-1601.
    PubMed     Text format    

  10. VERMA S, Leiter LA, Mazer CD, Bain SC, et al
    Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
    Circulation. 2018;138:1605-1607.
    PubMed     Text format    

  11. KOH KK
    Letter by Koh Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy Internat
    Circulation. 2018;138:1914-1915.
    PubMed     Text format    

  12. DONZELLI A, Schivalocchi A, Giudicatti G
    Letter by Donzelli et al Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Effica
    Circulation. 2018;138:1912-1913.
    PubMed     Text format    

  13. KOH KK
    Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:846-847.
    PubMed     Text format    

  14. WANNER C, von Eynatten M, Zinman B
    Response by Wanner et al to Letters Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:850-851.
    PubMed     Text format    

  15. TAMPAKIS A, Tampaki EC, Gurke L
    Letter by Tampakis et al Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:848-849.
    PubMed     Text format    


    Diabet Med

  16. ADAMS AS, Schmittdiel JA, Altschuler A, Bayliss EA, et al
    Automated symptom and treatment side effect monitoring for improved quality of life among adults with diabetic peripheral neuropathy in primary care: a pragmatic, cluster, randomized, controlled trial.
    Diabet Med. 2018 Oct 21. doi: 10.1111/dme.13840.
    PubMed     Text format     Abstract available

  17. POWELL WR, Christiansen CL, Miller DR
    Long-term comparative safety analysis of the risks associated with adding or switching to a sulfonylurea as second-line Type 2 diabetes mellitus treatment in a US Veterans Affairs population.
    Diabet Med. 2018 Oct 21. doi: 10.1111/dme.13839.
    PubMed     Text format     Abstract available

  18. BAKKE A, Tran AT, Dalen I, Cooper JG, et al
    Population, general practitioner and practice characteristics are associated with screening procedures for microvascular complications in Type 2 diabetes care in Norway.
    Diabet Med. 2018 Oct 21. doi: 10.1111/dme.13842.
    PubMed     Text format     Abstract available

  19. VARNI JW, Delamater AM, Hood KK, Raymond JK, et al
    Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for youth with Type 2 diabetes: reliability and validity.
    Diabet Med. 2018 Oct 21. doi: 10.1111/dme.13841.
    PubMed     Text format     Abstract available

  20. HOLT RIG
    Editor's Selection: This Month's Highlighted Articles: Predicting diabetic foot ulceration.
    Diabet Med. 2018;35:1469.
    PubMed     Text format    

  21. SENIOR PA, Pettus JH
    Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials.
    Diabet Med. 2018 Oct 25. doi: 10.1111/dme.13846.
    PubMed     Text format     Abstract available

  22. TAYLOR RAM, Mackie A, Mogra R, Pinner J, et al
    Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Diabet Med. 2018 Oct 25. doi: 10.1111/dme.13844.
    PubMed     Text format     Abstract available

  23. PANG T, Bain SC, Black RNA, Boyle JG, et al
    A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA).
    Diabet Med. 2018 Oct 25. doi: 10.1111/dme.13847.
    PubMed     Text format     Abstract available

  24. SECKOLD R, Fisher E, deBock M, King BR, et al
    The ups and downs of low-carbohydrate diets in the management of Type 1 diabetes: a review of clinical outcomes.
    Diabet Med. 2018 Oct 25. doi: 10.1111/dme.13845.
    PubMed     Text format     Abstract available


    Diabetes


  25. In This Issue of Diabetes.
    Diabetes. 2018;67:2127-2128.
    PubMed     Text format    

  26. FRIEDMAN JE
    Developmental Programming of Obesity and Diabetes in Mouse, Monkey, and Man in 2018: Where Are We Headed?
    Diabetes. 2018;67:2137-2151.
    PubMed     Text format     Abstract available

  27. DAI YD, Dias P
    Exosomes or Microvesicles, a Secreted Subcellular Organelle Contributing to Inflammation and Diabetes.
    Diabetes. 2018;67:2154-2156.
    PubMed     Text format    

  28. BUITINGA M, Callebaut A, Marques Camara Sodre F, Crevecoeur I, et al
    Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes.
    Diabetes. 2018;67:2337-2348.
    PubMed     Text format     Abstract available

  29. ZWAKENBERG SR, Remmelzwaal S, Beulens JWJ, Booth SL, et al
    Circulating Phylloquinone Concentrations and Risk of Type 2 Diabetes: a Mendelian Randomization Study.
    Diabetes. 2018 Oct 23. pii: db18-0543. doi: 10.2337/db18-0543.
    PubMed     Text format     Abstract available

  30. JI Y, Yiorkas AM, Frau F, Mook-Kanamori D, et al
    Genome-Wide and Abdominal MRI-Imaging Data Provides Evidence that a Genetically Determined Favourable Adiposity Phenotype is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease and Hypertension.
    Diabetes. 2018 Oct 23. pii: db18-0708. doi: 10.2337/db18-0708.
    PubMed     Text format     Abstract available

  31. MARTIN-MONTALVO A, Lopez-Noriega L, Jimenez-Moreno C, Herranz A, et al
    Transient PAX8 Expression in Islets During Pregnancy Correlates With Beta Cell Survival Revealing a Novel Candidate Gene in Gestational Diabetes Mellitus.
    Diabetes. 2018 Oct 23. pii: db18-0285. doi: 10.2337/db18-0285.
    PubMed     Text format     Abstract available

  32. RABBANI PS, Soares MA, Hameedi SG, Kadle RL, et al
    Dysregulation of Nrf2/Keap1 Redox Pathway in Diabetes Affects Multipotency of Stromal Cells.
    Diabetes. 2018 Oct 23. pii: db18-0232. doi: 10.2337/db18-0232.
    PubMed     Text format     Abstract available


    Diabetes Care


  33. In This Issue of Diabetes Care.
    Diabetes Care. 2018;41:2263-2264.
    PubMed     Text format    

  34. DONZELLI A, Schivalocchi A, Giudicatti G, Battaggia A, et al
    Comment on Itoh et al. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care 2018;41:1275-1284.
    Diabetes Care. 2018;41:e143-e144.
    PubMed     Text format    

  35. ITOH H, Ueshima K, Komuro I
    Response to Comment on Itoh et al. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care 2018;41:1275-1284.
    Diabetes Care. 2018;41:e145-e146.
    PubMed     Text format    

  36. RIGALLEAU V, Lecocq M, Rigo M, Monlun M, et al
    Comment on Andersen et al. Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care 2018;41:1955-1962.
    Diabetes Care. 2018;41:e147.
    PubMed     Text format    

  37. ANDERSEN ST, Witte DR, Andersen H, Bjerg L, et al
    Response to Comment on Andersen et al. Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care 2018;41:1955-1962.
    Diabetes Care. 2018;41:e148-e149.
    PubMed     Text format    

  38. LUO J, Hendryx M, Laddu D, Phillips LS, et al
    Racial and Ethnic Differences in Anthropometric Measures as Risk Factors for Diabetes.
    Diabetes Care. 2018 Oct 23. pii: dc18-1413. doi: 10.2337/dc18-1413.
    PubMed     Text format     Abstract available

  39. DANDONA P, Mathieu C, Phillip M, Hansen L, et al
    Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
    Diabetes Care. 2018 Oct 23. pii: dc18-1087. doi: 10.2337/dc18-1087.
    PubMed     Text format     Abstract available

  40. GRUBB AL, McDonald TJ, Rutters F, Donnelly LA, et al
    A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy.
    Diabetes Care. 2018 Oct 23. pii: dc18-0431. doi: 10.2337/dc18-0431.
    PubMed     Text format     Abstract available

  41. BECK RW, Bergenstal RM, Riddlesworth TD, Kollman C, et al
    Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
    Diabetes Care. 2018 Oct 23. pii: dc18-1444. doi: 10.2337/dc18-1444.
    PubMed     Text format     Abstract available

  42. GHOUSE J, Skov MW, Kanters JK, Lind B, et al
    Visit-to-Visit Variability of Hemoglobin A1c in People Without Diabetes and Risk of Major Adverse Cardiovascular Events and All-Cause Mortality.
    Diabetes Care. 2018 Oct 23. pii: dc18-1396. doi: 10.2337/dc18-1396.
    PubMed     Text format     Abstract available

  43. TOPPE C, Mollsten A, Waernbaum I, Schon S, et al
    Decreasing Cumulative Incidence of End-Stage Renal Disease in Young Patients With Type 1 Diabetes in Sweden: A 38-Year Prospective Nationwide Study.
    Diabetes Care. 2018 Oct 23. pii: dc18-1276. doi: 10.2337/dc18-1276.
    PubMed     Text format     Abstract available


    Diabetes Educ

  44. KENT DA, Quinn L
    Factors That Affect Quality of Life in Young Adults With Type 1 Diabetes.
    Diabetes Educ. 2018 Oct 20:145721718808733. doi: 10.1177/0145721718808733.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  45. DEVRIES JH, Bailey TS, Bhargava A, Gerety G, et al
    Day-to-day Fasting Self-monitored Blood Glucose Variability is Associated with Risk of Hypoglycaemia in Insulin-Treated Patients with Type 1 and Type 2 Diabetes: A Post Hoc Analysis of the SWITCH Trials.
    Diabetes Obes Metab. 2018 Oct 25. doi: 10.1111/dom.13565.
    PubMed     Text format     Abstract available

  46. HOVELMANN U, Braendholt Olsen M, Mouritzen U, Lamers D, et al
    Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.
    Diabetes Obes Metab. 2018 Oct 23. doi: 10.1111/dom.13562.
    PubMed     Text format     Abstract available

  47. VILJOEN A, Hoxer CS, Johansen P, Malkin S, et al
    Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly semaglutide versus dulaglutide for the treatment of type 2 diabetes mellitus in the UK.
    Diabetes Obes Metab. 2018 Oct 25. doi: 10.1111/dom.13564.
    PubMed     Text format     Abstract available

  48. KIM Y, Kang ES, Jang HC, Kim DJ, et al
    Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double-blind, non-inferiority trial.
    Diabetes Obes Metab. 2018 Oct 26. doi: 10.1111/dom.13566.
    PubMed     Text format     Abstract available


    Diabetologia

  49. GOLDBERG RB, Bray GA, Marcovina SM, Mather KJ, et al
    Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions.
    Diabetologia. 2018 Oct 17. pii: 10.1007/s00125-018-4748.
    PubMed     Text format     Abstract available

  50. BAO X, Borne Y, Muhammad IF, Nilsson J, et al
    Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmo Diet and Cancer-Cardiovascular Cohort.
    Diabetologia. 2018 Oct 22. pii: 10.1007/s00125-018-4751.
    PubMed     Text format     Abstract available

  51. ZHANG T, Xu J, Li S, Bazzano LA, et al
    Trajectories of childhood BMI and adult diabetes: the Bogalusa Heart Study.
    Diabetologia. 2018 Oct 20. pii: 10.1007/s00125-018-4753.
    PubMed     Text format     Abstract available

  52. LESLIE KA, Russell MA, Taniguchi K, Richardson SJ, et al
    The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes.
    Diabetologia. 2018 Oct 18. pii: 10.1007/s00125-018-4750.
    PubMed     Text format     Abstract available


    Hypertension

  53. LUO H, Chen C, Guo L, Xu Z, et al
    Exposure to Maternal Diabetes Mellitus Causes Renal Dopamine D1 Receptor Dysfunction and Hypertension in Adult Rat Offspring.
    Hypertension. 2018;72:962-970.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  54. VUJOSEVIC S, Muraca A, Gatti V, Masoero L, et al
    Peripapillary Microvascular and Neural Changes in Diabetes Mellitus: An OCT-Angiography Study.
    Invest Ophthalmol Vis Sci. 2018;59:5074-5081.
    PubMed     Text format     Abstract available

  55. MCANANY JJ, Park JC
    Temporal Frequency Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Electroretinography.
    Invest Ophthalmol Vis Sci. 2018;59:4871-4879.
    PubMed     Text format     Abstract available

  56. DURAISAMY AJ, Mishra M, Kowluru A, Kowluru RA, et al
    Epigenetics and Regulation of Oxidative Stress in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:4831-4840.
    PubMed     Text format     Abstract available

  57. JIN G, Xiao W, Ding X, Xu X, et al
    Prevalence of and Risk Factors for Diabetic Retinopathy in a Rural Chinese Population: The Yangxi Eye Study.
    Invest Ophthalmol Vis Sci. 2018;59:5067-5073.
    PubMed     Text format     Abstract available


    J Am Soc Nephrol

  58. ZHANG Y, Ma KL, Gong YX, Wang GH, et al
    Platelet Microparticles Mediate Glomerular Endothelial Injury in Early Diabetic Nephropathy.
    J Am Soc Nephrol. 2018 Oct 19. pii: ASN.2018040368. doi: 10.1681/ASN.2018040368.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  59. HIVERT MF, Christophi C, Jablonski K, Edelstein S, et al
    Genetic ancestry markers and difference in A1c between African-American and White in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2018 Oct 24. pii: 5143221. doi: 10.1210/jc.2018-01416.
    PubMed     Text format     Abstract available

  60. LASH RW
    Diabetes and Pregnancy-An Endocrine Society Clinical Practice Guideline Publication Note.
    J Clin Endocrinol Metab. 2018;103:4042.
    PubMed     Text format    

  61. CHAKRABORTY S, Halland M, Burton D, Desai A, et al
    GI Dysfunctions in Diabetic Gastroenteropathy, their Relationships with Symptoms, and Effects of a GLP-1 antagonist.
    J Clin Endocrinol Metab. 2018 Oct 24. pii: 5143220. doi: 10.1210/jc.2018-01623.
    PubMed     Text format     Abstract available

  62. ZHU J, Volkening LK, Laffel LM
    Determination of Pubertal Status in Youth with Type 1 Diabetes Using Height Velocity and Trajectories.
    J Clin Endocrinol Metab. 2018 Oct 19. pii: 5136074. doi: 10.1210/jc.2018-01737.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  63. MOSTAFA SA, Coleman RL, Agbaje OF, Gray AM, et al
    Simulating the impact of targeting lower systolic blood pressure and LDL-cholesterol levels on type 2 diabetes complication rates.
    J Diabetes Complications. 2018 Oct 10. pii: S1056-8727(18)30699.
    PubMed     Text format     Abstract available

  64. HJORTKJAER HO, Jensen T, Hilsted J, Mogensen UM, et al
    Left ventricular remodelling and cardiac chamber sizes in long-term, normoalbuminuric type 1 diabetes patients with and without cardiovascular autonomic neuropathy.
    J Diabetes Complications. 2018 Oct 11. pii: S1056-8727(18)30304.
    PubMed     Text format     Abstract available


    JAMA

  65. OSPINA NS, Young WF Jr, Ghayee HK
    Diagnostic Testing for Elevated Cortisol in the Setting of an Adrenal Mass.
    JAMA. 2018;320:1373-1374.
    PubMed     Text format    


    Med J Aust

  66. LIM WH, Johnson DW, Hawley C, Lok C, et al
    Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
    Med J Aust. 2018 Oct 22. pii: 10.5694/mja18.00195.
    PubMed     Text format     Abstract available


    Metabolism

  67. PATH G, Perakakis N, Mantzoros CS, Seufert J, et al
    Stem cells in the treatment of diabetes mellitus - focus on mesenchymal stem cells.
    Metabolism. 2018 Oct 17. pii: S0026-0495(18)30215.
    PubMed     Text format     Abstract available


    Nature

  68. VATANEN T, Franzosa EA, Schwager R, Tripathi S, et al
    The human gut microbiome in early-onset type 1 diabetes from the TEDDY study.
    Nature. 2018;562:589-594.
    PubMed     Text format     Abstract available


    Nutr Metab (Lond)

  69. YIN XL, Xu BQ, Zhang YQ
    Gynura divaricata rich in 3, 5-/4, 5-dicaffeoylquinic acid and chlorogenic acid reduces islet cell apoptosis and improves pancreatic function in type 2 diabetic mice.
    Nutr Metab (Lond). 2018;15:73.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  70. EKMAN I, Vuorinen T, Knip M, Veijola R, et al
    Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes.
    Pediatr Diabetes. 2018 Oct 18. doi: 10.1111/pedi.12788.
    PubMed     Text format     Abstract available

  71. FRASER IP, Neufeld ND, Fox LA, Kipnes MS, et al
    A Randomized Clinical Trial to Evaluate the Single-dose Pharmacokinetics, Pharmacodynamics and Safety of Sitagliptin in Pediatric Patients with Type 2 Diabetes.
    Pediatr Diabetes. 2018 Oct 22. doi: 10.1111/pedi.12790.
    PubMed     Text format     Abstract available


    PLoS One

  72. HEIER M, Espeland CN, Brunborg C, Seljeflot I, et al
    Preserved endothelial function in young adults with type 1 diabetes.
    PLoS One. 2018;13:e0206523.
    PubMed     Text format     Abstract available

  73. HUA Y, Bi R, Zhang Y, Xu L, et al
    Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.
    PLoS One. 2018;13:e0205503.
    PubMed     Text format     Abstract available

  74. SILVA CRS, Costa ADS, Rocha T, Lima DAM, et al
    Quadriceps muscle architecture ultrasonography of individuals with type 2 diabetes: Reliability and applicability.
    PLoS One. 2018;13:e0205724.
    PubMed     Text format     Abstract available

  75. LEE MC, Chiang CY, Lee CH, Ho CM, et al
    Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
    PLoS One. 2018;13:e0205807.
    PubMed     Text format     Abstract available

  76. CHANG E, Kim DH, Yang H, Lee DH, et al
    CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.
    PLoS One. 2018;13:e0206152.
    PubMed     Text format     Abstract available


    Retina

  77. FORTE R, Haulani H, Jurgens I
    QUANTITATIVE AND QUALITATIVE ANALYSIS OF THE THREE CAPILLARY PLEXUSES AND CHORIOCAPILLARIS IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS WITHOUT CLINICAL SIGNS OF DIABETIC RETINOPATHY: A Prospective Pilot Study.
    Retina. 2018 Oct 23. doi: 10.1097/IAE.0000000000002376.
    PubMed     Text format     Abstract available


    Stroke

  78. MA S, Wang J, Wang Y, Dai X, et al
    Diabetes Mellitus Impairs White Matter Repair and Long-Term Functional Deficits After Cerebral Ischemia.
    Stroke. 2018;49:2453-2463.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: